nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ALB—hepatitis B	0.473	1	CbGaD
Tacrolimus—ORM1—saliva—hepatitis B	0.0112	0.147	CbGeAlD
Tacrolimus—PPP3CA—blood plasma—hepatitis B	0.0094	0.123	CbGeAlD
Tacrolimus—MTOR—blood plasma—hepatitis B	0.00695	0.0909	CbGeAlD
Tacrolimus—FKBP1A—blood plasma—hepatitis B	0.00625	0.0817	CbGeAlD
Tacrolimus—ABCA5—blood—hepatitis B	0.0051	0.0667	CbGeAlD
Tacrolimus—ABCA5—liver—hepatitis B	0.00399	0.0522	CbGeAlD
Tacrolimus—PPP3CA—blood—hepatitis B	0.00344	0.0451	CbGeAlD
Tacrolimus—CYP3A5—blood plasma—hepatitis B	0.00272	0.0356	CbGeAlD
Tacrolimus—PPP3CA—liver—hepatitis B	0.00269	0.0352	CbGeAlD
Tacrolimus—MTOR—blood—hepatitis B	0.00254	0.0333	CbGeAlD
Tacrolimus—FKBP1A—blood—hepatitis B	0.00229	0.0299	CbGeAlD
Tacrolimus—CYP3A7—liver—hepatitis B	0.00221	0.029	CbGeAlD
Tacrolimus—CYP3A4—blood plasma—hepatitis B	0.00204	0.0267	CbGeAlD
Tacrolimus—MTOR—liver—hepatitis B	0.00199	0.026	CbGeAlD
Tacrolimus—CYP3A7-CYP3A51P—liver—hepatitis B	0.00188	0.0246	CbGeAlD
Tacrolimus—ORM1—blood—hepatitis B	0.00179	0.0234	CbGeAlD
Tacrolimus—FKBP1A—liver—hepatitis B	0.00179	0.0234	CbGeAlD
Tacrolimus—ABCB1—blood plasma—hepatitis B	0.00144	0.0189	CbGeAlD
Tacrolimus—ORM1—liver—hepatitis B	0.0014	0.0183	CbGeAlD
Tacrolimus—Blood triglycerides increased—Lamivudine—hepatitis B	0.00138	0.00432	CcSEcCtD
Tacrolimus—Blood creatinine increased—Entecavir—hepatitis B	0.00133	0.00416	CcSEcCtD
Tacrolimus—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0013	0.00406	CcSEcCtD
Tacrolimus—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00128	0.004	CcSEcCtD
Tacrolimus—ALB—liver—hepatitis B	0.00123	0.0161	CbGeAlD
Tacrolimus—Renal impairment—Telbivudine—hepatitis B	0.00123	0.00383	CcSEcCtD
Tacrolimus—Pancreatitis—Entecavir—hepatitis B	0.0012	0.00376	CcSEcCtD
Tacrolimus—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00117	0.00367	CcSEcCtD
Tacrolimus—Amblyopia—Lamivudine—hepatitis B	0.00117	0.00367	CcSEcCtD
Tacrolimus—Pain in extremity—Telbivudine—hepatitis B	0.00117	0.00365	CcSEcCtD
Tacrolimus—Hyperaesthesia—Lamivudine—hepatitis B	0.00115	0.00361	CcSEcCtD
Tacrolimus—Migraine—Telbivudine—hepatitis B	0.00115	0.00359	CcSEcCtD
Tacrolimus—Neutropenia—Entecavir—hepatitis B	0.00115	0.00359	CcSEcCtD
Tacrolimus—Hyperglycaemia—Entecavir—hepatitis B	0.00111	0.00346	CcSEcCtD
Tacrolimus—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00108	0.00339	CcSEcCtD
Tacrolimus—Acne—Lamivudine—hepatitis B	0.00108	0.00337	CcSEcCtD
Tacrolimus—Renal failure—Entecavir—hepatitis B	0.00108	0.00336	CcSEcCtD
Tacrolimus—Cramp muscle—Telbivudine—hepatitis B	0.00105	0.00328	CcSEcCtD
Tacrolimus—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00105	0.00328	CcSEcCtD
Tacrolimus—Haematuria—Entecavir—hepatitis B	0.00104	0.00326	CcSEcCtD
Tacrolimus—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00104	0.00325	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Entecavir—hepatitis B	0.00104	0.00324	CcSEcCtD
Tacrolimus—Gastritis—Telbivudine—hepatitis B	0.00103	0.00323	CcSEcCtD
Tacrolimus—Muscular weakness—Telbivudine—hepatitis B	0.00103	0.00322	CcSEcCtD
Tacrolimus—Rhabdomyolysis—Lamivudine—hepatitis B	0.00102	0.0032	CcSEcCtD
Tacrolimus—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00102	0.00318	CcSEcCtD
Tacrolimus—Abdominal distension—Telbivudine—hepatitis B	0.00102	0.00317	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00101	0.00316	CcSEcCtD
Tacrolimus—Influenza—Telbivudine—hepatitis B	0.00101	0.00315	CcSEcCtD
Tacrolimus—Bone disorder—Lamivudine—hepatitis B	0.001	0.00314	CcSEcCtD
Tacrolimus—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.001	0.00313	CcSEcCtD
Tacrolimus—CYP3A5—blood—hepatitis B	0.000996	0.013	CbGeAlD
Tacrolimus—Hepatitis—Entecavir—hepatitis B	0.000983	0.00307	CcSEcCtD
Tacrolimus—Oedema peripheral—Entecavir—hepatitis B	0.000968	0.00303	CcSEcCtD
Tacrolimus—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.000959	0.003	CcSEcCtD
Tacrolimus—Hypercholesterolaemia—Lamivudine—hepatitis B	0.000958	0.00299	CcSEcCtD
Tacrolimus—Hearing impaired—Lamivudine—hepatitis B	0.000952	0.00297	CcSEcCtD
Tacrolimus—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.000952	0.00297	CcSEcCtD
Tacrolimus—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.000947	0.00296	CcSEcCtD
Tacrolimus—Neutropenia—Telbivudine—hepatitis B	0.000943	0.00295	CcSEcCtD
Tacrolimus—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.000942	0.00295	CcSEcCtD
Tacrolimus—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00094	0.00294	CcSEcCtD
Tacrolimus—Inflammation—Lamivudine—hepatitis B	0.000934	0.00292	CcSEcCtD
Tacrolimus—Immune system disorder—Entecavir—hepatitis B	0.000888	0.00277	CcSEcCtD
Tacrolimus—Renal failure—Telbivudine—hepatitis B	0.000884	0.00276	CcSEcCtD
Tacrolimus—Neuropathy peripheral—Telbivudine—hepatitis B	0.000882	0.00276	CcSEcCtD
Tacrolimus—Alopecia—Entecavir—hepatitis B	0.000869	0.00271	CcSEcCtD
Tacrolimus—Mental disorder—Entecavir—hepatitis B	0.000861	0.00269	CcSEcCtD
Tacrolimus—Malnutrition—Entecavir—hepatitis B	0.000856	0.00267	CcSEcCtD
Tacrolimus—Photophobia—Lamivudine—hepatitis B	0.000851	0.00266	CcSEcCtD
Tacrolimus—Neuropathy—Lamivudine—hepatitis B	0.000851	0.00266	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Telbivudine—hepatitis B	0.000851	0.00266	CcSEcCtD
Tacrolimus—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.000835	0.00261	CcSEcCtD
Tacrolimus—Flatulence—Adefovir Dipivoxil—hepatitis B	0.000823	0.00257	CcSEcCtD
Tacrolimus—Mouth ulceration—Lamivudine—hepatitis B	0.000819	0.00256	CcSEcCtD
Tacrolimus—Back pain—Adefovir Dipivoxil—hepatitis B	0.000808	0.00252	CcSEcCtD
Tacrolimus—Hepatitis—Telbivudine—hepatitis B	0.000807	0.00252	CcSEcCtD
Tacrolimus—Hypoaesthesia—Telbivudine—hepatitis B	0.000803	0.00251	CcSEcCtD
Tacrolimus—Pharyngitis—Telbivudine—hepatitis B	0.000801	0.0025	CcSEcCtD
Tacrolimus—Connective tissue disorder—Telbivudine—hepatitis B	0.000793	0.00248	CcSEcCtD
Tacrolimus—Sepsis—Lamivudine—hepatitis B	0.000786	0.00246	CcSEcCtD
Tacrolimus—CYP3A5—liver—hepatitis B	0.000779	0.0102	CbGeAlD
Tacrolimus—Anaemia—Adefovir Dipivoxil—hepatitis B	0.000772	0.00241	CcSEcCtD
Tacrolimus—Lymphadenopathy—Lamivudine—hepatitis B	0.000771	0.00241	CcSEcCtD
Tacrolimus—Leukopenia—Entecavir—hepatitis B	0.000766	0.00239	CcSEcCtD
Tacrolimus—Phlebitis—Lamivudine—hepatitis B	0.000764	0.00239	CcSEcCtD
Tacrolimus—CYP3A4—blood—hepatitis B	0.000748	0.00978	CbGeAlD
Tacrolimus—Gastroenteritis—Lamivudine—hepatitis B	0.000742	0.00232	CcSEcCtD
Tacrolimus—Deafness—Lamivudine—hepatitis B	0.000735	0.0023	CcSEcCtD
Tacrolimus—Cough—Adefovir Dipivoxil—hepatitis B	0.000728	0.00228	CcSEcCtD
Tacrolimus—Mediastinal disorder—Telbivudine—hepatitis B	0.000728	0.00227	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.000723	0.00226	CcSEcCtD
Tacrolimus—Injury—Lamivudine—hepatitis B	0.000716	0.00224	CcSEcCtD
Tacrolimus—Myalgia—Adefovir Dipivoxil—hepatitis B	0.000711	0.00222	CcSEcCtD
Tacrolimus—Chest pain—Adefovir Dipivoxil—hepatitis B	0.000711	0.00222	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.000706	0.00221	CcSEcCtD
Tacrolimus—Malnutrition—Telbivudine—hepatitis B	0.000703	0.0022	CcSEcCtD
Tacrolimus—Anaphylactic shock—Entecavir—hepatitis B	0.000698	0.00218	CcSEcCtD
Tacrolimus—Infection—Entecavir—hepatitis B	0.000694	0.00217	CcSEcCtD
Tacrolimus—Thirst—Lamivudine—hepatitis B	0.000691	0.00216	CcSEcCtD
Tacrolimus—Renal impairment—Lamivudine—hepatitis B	0.000691	0.00216	CcSEcCtD
Tacrolimus—Dysgeusia—Telbivudine—hepatitis B	0.000688	0.00215	CcSEcCtD
Tacrolimus—Nervous system disorder—Entecavir—hepatitis B	0.000685	0.00214	CcSEcCtD
Tacrolimus—Back pain—Telbivudine—hepatitis B	0.00068	0.00212	CcSEcCtD
Tacrolimus—Skin disorder—Entecavir—hepatitis B	0.000678	0.00212	CcSEcCtD
Tacrolimus—Muscle spasms—Telbivudine—hepatitis B	0.000676	0.00211	CcSEcCtD
Tacrolimus—Hypoglycaemia—Lamivudine—hepatitis B	0.000674	0.00211	CcSEcCtD
Tacrolimus—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.000668	0.00209	CcSEcCtD
Tacrolimus—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.000667	0.00208	CcSEcCtD
Tacrolimus—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.000662	0.00207	CcSEcCtD
Tacrolimus—Ill-defined disorder—Telbivudine—hepatitis B	0.000652	0.00204	CcSEcCtD
Tacrolimus—Anorexia—Adefovir Dipivoxil—hepatitis B	0.000649	0.00203	CcSEcCtD
Tacrolimus—Migraine—Lamivudine—hepatitis B	0.000647	0.00202	CcSEcCtD
Tacrolimus—Affect lability—Lamivudine—hepatitis B	0.000647	0.00202	CcSEcCtD
Tacrolimus—Malaise—Telbivudine—hepatitis B	0.000634	0.00198	CcSEcCtD
Tacrolimus—Insomnia—Entecavir—hepatitis B	0.000632	0.00197	CcSEcCtD
Tacrolimus—Mood swings—Lamivudine—hepatitis B	0.000623	0.00195	CcSEcCtD
Tacrolimus—Somnolence—Entecavir—hepatitis B	0.000621	0.00194	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.000621	0.00194	CcSEcCtD
Tacrolimus—Dyspepsia—Entecavir—hepatitis B	0.000615	0.00192	CcSEcCtD
Tacrolimus—Cough—Telbivudine—hepatitis B	0.000613	0.00192	CcSEcCtD
Tacrolimus—Dehydration—Lamivudine—hepatitis B	0.000612	0.00191	CcSEcCtD
Tacrolimus—Liver function test abnormal—Lamivudine—hepatitis B	0.000607	0.0019	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Entecavir—hepatitis B	0.000603	0.00188	CcSEcCtD
Tacrolimus—Fatigue—Entecavir—hepatitis B	0.000602	0.00188	CcSEcCtD
Tacrolimus—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0006	0.00187	CcSEcCtD
Tacrolimus—Arthralgia—Telbivudine—hepatitis B	0.000598	0.00187	CcSEcCtD
Tacrolimus—Myalgia—Telbivudine—hepatitis B	0.000598	0.00187	CcSEcCtD
Tacrolimus—Chest pain—Telbivudine—hepatitis B	0.000598	0.00187	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.000594	0.00186	CcSEcCtD
Tacrolimus—Cramp muscle—Lamivudine—hepatitis B	0.000592	0.00185	CcSEcCtD
Tacrolimus—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.000592	0.00185	CcSEcCtD
Tacrolimus—Discomfort—Telbivudine—hepatitis B	0.000591	0.00185	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.000588	0.00184	CcSEcCtD
Tacrolimus—CYP3A4—liver—hepatitis B	0.000585	0.00765	CbGeAlD
Tacrolimus—Muscular weakness—Lamivudine—hepatitis B	0.00058	0.00181	CcSEcCtD
Tacrolimus—Abdominal distension—Lamivudine—hepatitis B	0.000572	0.00179	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Entecavir—hepatitis B	0.000571	0.00178	CcSEcCtD
Tacrolimus—Dysphagia—Lamivudine—hepatitis B	0.000569	0.00178	CcSEcCtD
Tacrolimus—Influenza—Lamivudine—hepatitis B	0.000569	0.00178	CcSEcCtD
Tacrolimus—Nervous system disorder—Telbivudine—hepatitis B	0.000563	0.00176	CcSEcCtD
Tacrolimus—Thrombocytopenia—Telbivudine—hepatitis B	0.000562	0.00176	CcSEcCtD
Tacrolimus—Pancreatitis—Lamivudine—hepatitis B	0.000557	0.00174	CcSEcCtD
Tacrolimus—Skin disorder—Telbivudine—hepatitis B	0.000557	0.00174	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.000557	0.00174	CcSEcCtD
Tacrolimus—Sweating increased—Lamivudine—hepatitis B	0.000554	0.00173	CcSEcCtD
Tacrolimus—Abdominal pain—Entecavir—hepatitis B	0.000552	0.00173	CcSEcCtD
Tacrolimus—Body temperature increased—Entecavir—hepatitis B	0.000552	0.00173	CcSEcCtD
Tacrolimus—Bronchitis—Lamivudine—hepatitis B	0.000547	0.00171	CcSEcCtD
Tacrolimus—Pancytopenia—Lamivudine—hepatitis B	0.00054	0.00169	CcSEcCtD
Tacrolimus—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.000539	0.00168	CcSEcCtD
Tacrolimus—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.000539	0.00168	CcSEcCtD
Tacrolimus—Dysuria—Lamivudine—hepatitis B	0.000532	0.00166	CcSEcCtD
Tacrolimus—Neutropenia—Lamivudine—hepatitis B	0.000532	0.00166	CcSEcCtD
Tacrolimus—ABCB1—blood—hepatitis B	0.000529	0.00693	CbGeAlD
Tacrolimus—Pollakiuria—Lamivudine—hepatitis B	0.000525	0.00164	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.000523	0.00163	CcSEcCtD
Tacrolimus—Insomnia—Telbivudine—hepatitis B	0.000519	0.00162	CcSEcCtD
Tacrolimus—Paraesthesia—Telbivudine—hepatitis B	0.000515	0.00161	CcSEcCtD
Tacrolimus—Hyperglycaemia—Lamivudine—hepatitis B	0.000513	0.0016	CcSEcCtD
Tacrolimus—Depression—Lamivudine—hepatitis B	0.000505	0.00158	CcSEcCtD
Tacrolimus—Dyspepsia—Telbivudine—hepatitis B	0.000505	0.00158	CcSEcCtD
Tacrolimus—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.000503	0.00157	CcSEcCtD
Tacrolimus—Asthenia—Entecavir—hepatitis B	0.000501	0.00157	CcSEcCtD
Tacrolimus—Renal failure—Lamivudine—hepatitis B	0.000498	0.00156	CcSEcCtD
Tacrolimus—Neuropathy peripheral—Lamivudine—hepatitis B	0.000497	0.00155	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Telbivudine—hepatitis B	0.000495	0.00155	CcSEcCtD
Tacrolimus—Fatigue—Telbivudine—hepatitis B	0.000495	0.00155	CcSEcCtD
Tacrolimus—Stomatitis—Lamivudine—hepatitis B	0.000494	0.00154	CcSEcCtD
Tacrolimus—Jaundice—Lamivudine—hepatitis B	0.000494	0.00154	CcSEcCtD
Tacrolimus—Pain—Telbivudine—hepatitis B	0.000491	0.00153	CcSEcCtD
Tacrolimus—Asthenia—Adefovir Dipivoxil—hepatitis B	0.000489	0.00153	CcSEcCtD
Tacrolimus—Sweating—Lamivudine—hepatitis B	0.000486	0.00152	CcSEcCtD
Tacrolimus—Pruritus—Adefovir Dipivoxil—hepatitis B	0.000482	0.00151	CcSEcCtD
Tacrolimus—Hepatobiliary disease—Lamivudine—hepatitis B	0.000479	0.0015	CcSEcCtD
Tacrolimus—Epistaxis—Lamivudine—hepatitis B	0.000478	0.00149	CcSEcCtD
Tacrolimus—Diarrhoea—Entecavir—hepatitis B	0.000478	0.00149	CcSEcCtD
Tacrolimus—Sinusitis—Lamivudine—hepatitis B	0.000476	0.00149	CcSEcCtD
Tacrolimus—Agranulocytosis—Lamivudine—hepatitis B	0.000473	0.00148	CcSEcCtD
Tacrolimus—Feeling abnormal—Telbivudine—hepatitis B	0.000473	0.00148	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Telbivudine—hepatitis B	0.000469	0.00147	CcSEcCtD
Tacrolimus—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.000466	0.00146	CcSEcCtD
Tacrolimus—Dizziness—Entecavir—hepatitis B	0.000462	0.00144	CcSEcCtD
Tacrolimus—Rhinitis—Lamivudine—hepatitis B	0.000456	0.00143	CcSEcCtD
Tacrolimus—Hepatitis—Lamivudine—hepatitis B	0.000455	0.00142	CcSEcCtD
Tacrolimus—Abdominal pain—Telbivudine—hepatitis B	0.000453	0.00142	CcSEcCtD
Tacrolimus—Body temperature increased—Telbivudine—hepatitis B	0.000453	0.00142	CcSEcCtD
Tacrolimus—Hypoaesthesia—Lamivudine—hepatitis B	0.000453	0.00141	CcSEcCtD
Tacrolimus—Pharyngitis—Lamivudine—hepatitis B	0.000452	0.00141	CcSEcCtD
Tacrolimus—Connective tissue disorder—Lamivudine—hepatitis B	0.000447	0.0014	CcSEcCtD
Tacrolimus—Vomiting—Entecavir—hepatitis B	0.000444	0.00139	CcSEcCtD
Tacrolimus—Rash—Entecavir—hepatitis B	0.00044	0.00138	CcSEcCtD
Tacrolimus—Dermatitis—Entecavir—hepatitis B	0.00044	0.00137	CcSEcCtD
Tacrolimus—Headache—Entecavir—hepatitis B	0.000437	0.00137	CcSEcCtD
Tacrolimus—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000433	0.00135	CcSEcCtD
Tacrolimus—Erythema multiforme—Lamivudine—hepatitis B	0.00043	0.00134	CcSEcCtD
Tacrolimus—Rash—Adefovir Dipivoxil—hepatitis B	0.00043	0.00134	CcSEcCtD
Tacrolimus—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000429	0.00134	CcSEcCtD
Tacrolimus—Headache—Adefovir Dipivoxil—hepatitis B	0.000427	0.00133	CcSEcCtD
Tacrolimus—Nausea—Entecavir—hepatitis B	0.000415	0.0013	CcSEcCtD
Tacrolimus—ABCB1—liver—hepatitis B	0.000414	0.00542	CbGeAlD
Tacrolimus—Asthenia—Telbivudine—hepatitis B	0.000412	0.00129	CcSEcCtD
Tacrolimus—Immune system disorder—Lamivudine—hepatitis B	0.000411	0.00128	CcSEcCtD
Tacrolimus—Mediastinal disorder—Lamivudine—hepatitis B	0.00041	0.00128	CcSEcCtD
Tacrolimus—Chills—Lamivudine—hepatitis B	0.000408	0.00128	CcSEcCtD
Tacrolimus—Pruritus—Telbivudine—hepatitis B	0.000406	0.00127	CcSEcCtD
Tacrolimus—Nausea—Adefovir Dipivoxil—hepatitis B	0.000405	0.00126	CcSEcCtD
Tacrolimus—Alopecia—Lamivudine—hepatitis B	0.000402	0.00126	CcSEcCtD
Tacrolimus—Erythema—Lamivudine—hepatitis B	0.000396	0.00124	CcSEcCtD
Tacrolimus—Malnutrition—Lamivudine—hepatitis B	0.000396	0.00124	CcSEcCtD
Tacrolimus—Diarrhoea—Telbivudine—hepatitis B	0.000393	0.00123	CcSEcCtD
Tacrolimus—Flatulence—Lamivudine—hepatitis B	0.00039	0.00122	CcSEcCtD
Tacrolimus—Tension—Lamivudine—hepatitis B	0.000389	0.00121	CcSEcCtD
Tacrolimus—Dysgeusia—Lamivudine—hepatitis B	0.000388	0.00121	CcSEcCtD
Tacrolimus—Nervousness—Lamivudine—hepatitis B	0.000385	0.0012	CcSEcCtD
Tacrolimus—Back pain—Lamivudine—hepatitis B	0.000383	0.0012	CcSEcCtD
Tacrolimus—Muscle spasms—Lamivudine—hepatitis B	0.000381	0.00119	CcSEcCtD
Tacrolimus—Dizziness—Telbivudine—hepatitis B	0.000379	0.00119	CcSEcCtD
Tacrolimus—Tremor—Lamivudine—hepatitis B	0.000371	0.00116	CcSEcCtD
Tacrolimus—Ill-defined disorder—Lamivudine—hepatitis B	0.000368	0.00115	CcSEcCtD
Tacrolimus—Anaemia—Lamivudine—hepatitis B	0.000366	0.00114	CcSEcCtD
Tacrolimus—Vomiting—Telbivudine—hepatitis B	0.000365	0.00114	CcSEcCtD
Tacrolimus—Rash—Telbivudine—hepatitis B	0.000362	0.00113	CcSEcCtD
Tacrolimus—Dermatitis—Telbivudine—hepatitis B	0.000361	0.00113	CcSEcCtD
Tacrolimus—Headache—Telbivudine—hepatitis B	0.000359	0.00112	CcSEcCtD
Tacrolimus—Malaise—Lamivudine—hepatitis B	0.000357	0.00112	CcSEcCtD
Tacrolimus—Vertigo—Lamivudine—hepatitis B	0.000356	0.00111	CcSEcCtD
Tacrolimus—Syncope—Lamivudine—hepatitis B	0.000355	0.00111	CcSEcCtD
Tacrolimus—Leukopenia—Lamivudine—hepatitis B	0.000355	0.00111	CcSEcCtD
Tacrolimus—Loss of consciousness—Lamivudine—hepatitis B	0.000348	0.00109	CcSEcCtD
Tacrolimus—Cough—Lamivudine—hepatitis B	0.000346	0.00108	CcSEcCtD
Tacrolimus—Convulsion—Lamivudine—hepatitis B	0.000343	0.00107	CcSEcCtD
Tacrolimus—Nausea—Telbivudine—hepatitis B	0.000341	0.00106	CcSEcCtD
Tacrolimus—Chest pain—Lamivudine—hepatitis B	0.000337	0.00105	CcSEcCtD
Tacrolimus—Arthralgia—Lamivudine—hepatitis B	0.000337	0.00105	CcSEcCtD
Tacrolimus—Myalgia—Lamivudine—hepatitis B	0.000337	0.00105	CcSEcCtD
Tacrolimus—Anxiety—Lamivudine—hepatitis B	0.000336	0.00105	CcSEcCtD
Tacrolimus—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000335	0.00105	CcSEcCtD
Tacrolimus—Discomfort—Lamivudine—hepatitis B	0.000333	0.00104	CcSEcCtD
Tacrolimus—Dry mouth—Lamivudine—hepatitis B	0.00033	0.00103	CcSEcCtD
Tacrolimus—Confusional state—Lamivudine—hepatitis B	0.000326	0.00102	CcSEcCtD
Tacrolimus—Oedema—Lamivudine—hepatitis B	0.000323	0.00101	CcSEcCtD
Tacrolimus—Anaphylactic shock—Lamivudine—hepatitis B	0.000323	0.00101	CcSEcCtD
Tacrolimus—Infection—Lamivudine—hepatitis B	0.000321	0.001	CcSEcCtD
Tacrolimus—Shock—Lamivudine—hepatitis B	0.000318	0.000994	CcSEcCtD
Tacrolimus—Nervous system disorder—Lamivudine—hepatitis B	0.000317	0.000991	CcSEcCtD
Tacrolimus—Thrombocytopenia—Lamivudine—hepatitis B	0.000317	0.000989	CcSEcCtD
Tacrolimus—Skin disorder—Lamivudine—hepatitis B	0.000314	0.000981	CcSEcCtD
Tacrolimus—Hyperhidrosis—Lamivudine—hepatitis B	0.000313	0.000977	CcSEcCtD
Tacrolimus—Anorexia—Lamivudine—hepatitis B	0.000308	0.000963	CcSEcCtD
Tacrolimus—Hypotension—Lamivudine—hepatitis B	0.000302	0.000944	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000295	0.00092	CcSEcCtD
Tacrolimus—Insomnia—Lamivudine—hepatitis B	0.000292	0.000914	CcSEcCtD
Tacrolimus—Paraesthesia—Lamivudine—hepatitis B	0.00029	0.000907	CcSEcCtD
Tacrolimus—Dyspnoea—Lamivudine—hepatitis B	0.000288	0.000901	CcSEcCtD
Tacrolimus—Somnolence—Lamivudine—hepatitis B	0.000287	0.000898	CcSEcCtD
Tacrolimus—Dyspepsia—Lamivudine—hepatitis B	0.000285	0.000889	CcSEcCtD
Tacrolimus—Decreased appetite—Lamivudine—hepatitis B	0.000281	0.000878	CcSEcCtD
Tacrolimus—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000279	0.000872	CcSEcCtD
Tacrolimus—Fatigue—Lamivudine—hepatitis B	0.000279	0.000871	CcSEcCtD
Tacrolimus—Constipation—Lamivudine—hepatitis B	0.000276	0.000864	CcSEcCtD
Tacrolimus—Pain—Lamivudine—hepatitis B	0.000276	0.000864	CcSEcCtD
Tacrolimus—Feeling abnormal—Lamivudine—hepatitis B	0.000266	0.000833	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Lamivudine—hepatitis B	0.000264	0.000826	CcSEcCtD
Tacrolimus—Urticaria—Lamivudine—hepatitis B	0.000257	0.000803	CcSEcCtD
Tacrolimus—Abdominal pain—Lamivudine—hepatitis B	0.000256	0.000799	CcSEcCtD
Tacrolimus—Body temperature increased—Lamivudine—hepatitis B	0.000256	0.000799	CcSEcCtD
Tacrolimus—Hypersensitivity—Lamivudine—hepatitis B	0.000238	0.000744	CcSEcCtD
Tacrolimus—Asthenia—Lamivudine—hepatitis B	0.000232	0.000725	CcSEcCtD
Tacrolimus—Pruritus—Lamivudine—hepatitis B	0.000229	0.000715	CcSEcCtD
Tacrolimus—Diarrhoea—Lamivudine—hepatitis B	0.000221	0.000691	CcSEcCtD
Tacrolimus—Dizziness—Lamivudine—hepatitis B	0.000214	0.000668	CcSEcCtD
Tacrolimus—Vomiting—Lamivudine—hepatitis B	0.000206	0.000642	CcSEcCtD
Tacrolimus—Rash—Lamivudine—hepatitis B	0.000204	0.000637	CcSEcCtD
Tacrolimus—Dermatitis—Lamivudine—hepatitis B	0.000204	0.000636	CcSEcCtD
Tacrolimus—Headache—Lamivudine—hepatitis B	0.000203	0.000633	CcSEcCtD
Tacrolimus—Nausea—Lamivudine—hepatitis B	0.000192	0.0006	CcSEcCtD
Tacrolimus—ALB—Selenium Micronutrient Network—IFNG—hepatitis B	0.000103	0.000786	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IFNB1—hepatitis B	0.000102	0.000783	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—CDKN1A—hepatitis B	0.0001	0.000766	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1A—hepatitis B	0.0001	0.000766	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—CDKN1A—hepatitis B	0.0001	0.000766	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—PTEN—hepatitis B	0.0001	0.000765	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—PTEN—hepatitis B	0.0001	0.000765	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PTEN—hepatitis B	0.0001	0.000765	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IFNA1—hepatitis B	9.98e-05	0.000764	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—hepatitis B	9.95e-05	0.000761	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—CDKN1A—hepatitis B	9.93e-05	0.00076	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—PTEN—hepatitis B	9.91e-05	0.000758	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—CDKN1A—hepatitis B	9.84e-05	0.000753	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—PTEN—hepatitis B	9.82e-05	0.000751	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IFNG—hepatitis B	9.82e-05	0.000751	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—CDKN1A—hepatitis B	9.8e-05	0.00075	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—PTEN—hepatitis B	9.78e-05	0.000748	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IL6—hepatitis B	9.48e-05	0.000725	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MX1—hepatitis B	9.42e-05	0.000721	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—hepatitis B	9.34e-05	0.000715	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HLA-A—hepatitis B	9.3e-05	0.000711	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD14—hepatitis B	9.29e-05	0.000711	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IFNA2—hepatitis B	9.29e-05	0.000711	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—CDKN1A—hepatitis B	9.27e-05	0.000709	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—PTEN—hepatitis B	9.25e-05	0.000708	CbGpPWpGaD
Tacrolimus—MTOR—B Cell Activation—NFKB1—hepatitis B	9.21e-05	0.000704	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—GOT1—hepatitis B	9.15e-05	0.0007	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CTNNB1—hepatitis B	9.14e-05	0.000699	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—F2—hepatitis B	8.96e-05	0.000685	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—CDKN1A—hepatitis B	8.93e-05	0.000683	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—PTEN—hepatitis B	8.91e-05	0.000681	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—CDKN2A—hepatitis B	8.9e-05	0.000681	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	8.88e-05	0.000679	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—NFKB1—hepatitis B	8.87e-05	0.000678	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	8.86e-05	0.000677	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—IL6—hepatitis B	8.82e-05	0.000675	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CCR5—hepatitis B	8.81e-05	0.000674	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SAG—hepatitis B	8.79e-05	0.000672	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—RIT2—hepatitis B	8.79e-05	0.000672	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by Insulin receptor—IL6—hepatitis B	8.76e-05	0.00067	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—IL2—hepatitis B	8.72e-05	0.000667	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—HLA-A—hepatitis B	8.59e-05	0.000657	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	8.56e-05	0.000655	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—NFKB1—hepatitis B	8.55e-05	0.000654	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—TLR4—hepatitis B	8.51e-05	0.000651	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—HLA-DRB1—hepatitis B	8.5e-05	0.00065	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TNF—hepatitis B	8.37e-05	0.00064	CbGpPWpGaD
Tacrolimus—ALB—Vitamin B12 Metabolism—IL6—hepatitis B	8.3e-05	0.000635	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CXCL10—hepatitis B	7.96e-05	0.000609	CbGpPWpGaD
Tacrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—hepatitis B	7.75e-05	0.000593	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—TGFB1—hepatitis B	7.69e-05	0.000588	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	7.66e-05	0.000586	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD40LG—hepatitis B	7.59e-05	0.00058	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—AKR1B1—hepatitis B	7.5e-05	0.000574	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD8A—hepatitis B	7.5e-05	0.000574	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by SCF-KIT—IL6—hepatitis B	7.49e-05	0.000573	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—NOS2—hepatitis B	7.47e-05	0.000571	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	7.38e-05	0.000565	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—TP53—hepatitis B	7.38e-05	0.000565	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—hepatitis B	7.32e-05	0.00056	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—CDKN1A—hepatitis B	7.28e-05	0.000557	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—NFKB1—hepatitis B	7.23e-05	0.000553	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GGT2—hepatitis B	7.19e-05	0.00055	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—IL6—hepatitis B	7.17e-05	0.000548	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—IL6—hepatitis B	7.05e-05	0.00054	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CCR5—hepatitis B	6.83e-05	0.000523	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—CDKN1A—hepatitis B	6.83e-05	0.000522	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—PTEN—hepatitis B	6.81e-05	0.000521	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TGFB1—hepatitis B	6.8e-05	0.00052	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—NFKB1—hepatitis B	6.78e-05	0.000518	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL6—hepatitis B	6.76e-05	0.000517	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—IL6—hepatitis B	6.74e-05	0.000515	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—IL6—hepatitis B	6.7e-05	0.000513	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-A—hepatitis B	6.69e-05	0.000511	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GGT1—hepatitis B	6.69e-05	0.000511	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—hepatitis B	6.67e-05	0.00051	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—HLA-A—hepatitis B	6.66e-05	0.000509	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—hepatitis B	6.65e-05	0.000509	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—hepatitis B	6.64e-05	0.000508	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HSPA5—hepatitis B	6.61e-05	0.000505	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—F2—hepatitis B	6.49e-05	0.000496	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—TLR4—hepatitis B	6.37e-05	0.000487	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—hepatitis B	6.35e-05	0.000486	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	6.25e-05	0.000478	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—hepatitis B	6.25e-05	0.000478	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—IL6—hepatitis B	6.25e-05	0.000478	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DPB1—hepatitis B	6.24e-05	0.000477	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IFNG—hepatitis B	6.21e-05	0.000475	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HSPA5—hepatitis B	6.19e-05	0.000474	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—IL6—hepatitis B	6.19e-05	0.000473	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CCR5—hepatitis B	6.17e-05	0.000472	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CXCL10—hepatitis B	6.17e-05	0.000472	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—hepatitis B	6.13e-05	0.000469	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—HLA-DRB1—hepatitis B	6.11e-05	0.000467	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—IL6—hepatitis B	6.11e-05	0.000467	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL2—hepatitis B	6.04e-05	0.000462	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR2—hepatitis B	6e-05	0.000459	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CD4—hepatitis B	5.99e-05	0.000458	CbGpPWpGaD
Tacrolimus—MTOR—Disease—GOT2—hepatitis B	5.96e-05	0.000456	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNB1—hepatitis B	5.96e-05	0.000456	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNA1—hepatitis B	5.82e-05	0.000445	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—NOS2—hepatitis B	5.79e-05	0.000443	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IFNB1—hepatitis B	5.59e-05	0.000427	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—hepatitis B	5.56e-05	0.000426	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CD4—hepatitis B	5.53e-05	0.000423	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	5.53e-05	0.000423	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL2—hepatitis B	5.51e-05	0.000422	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IFNA1—hepatitis B	5.45e-05	0.000417	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—AKR1B1—hepatitis B	5.42e-05	0.000415	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD14—hepatitis B	5.41e-05	0.000414	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNA2—hepatitis B	5.41e-05	0.000414	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—hepatitis B	5.37e-05	0.000411	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CTNNB1—hepatitis B	5.32e-05	0.000407	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—F2—hepatitis B	5.29e-05	0.000405	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CDKN1A—hepatitis B	5.2e-05	0.000398	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GGT2—hepatitis B	5.2e-05	0.000398	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PTEN—hepatitis B	5.19e-05	0.000397	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—NFKB1—hepatitis B	5.16e-05	0.000395	CbGpPWpGaD
Tacrolimus—MTOR—Disease—GOT1—hepatitis B	5.15e-05	0.000394	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IFNA2—hepatitis B	5.07e-05	0.000388	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—TP53—hepatitis B	4.96e-05	0.000379	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CTNNB1—hepatitis B	4.91e-05	0.000376	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—CDKN1A—hepatitis B	4.8e-05	0.000367	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PTEN—hepatitis B	4.79e-05	0.000366	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CCR5—hepatitis B	4.78e-05	0.000366	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.76e-05	0.000364	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—AKR1B1—hepatitis B	4.67e-05	0.000357	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL18—hepatitis B	4.62e-05	0.000353	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD40LG—hepatitis B	4.6e-05	0.000352	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD8A—hepatitis B	4.55e-05	0.000348	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—hepatitis B	4.54e-05	0.000347	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CD4—hepatitis B	4.49e-05	0.000343	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GGT2—hepatitis B	4.48e-05	0.000343	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IL2—hepatitis B	4.37e-05	0.000334	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP2A6—hepatitis B	4.36e-05	0.000333	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CD4—hepatitis B	4.31e-05	0.00033	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CD4—hepatitis B	4.29e-05	0.000328	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—hepatitis B	4.25e-05	0.000325	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	4.16e-05	0.000318	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—F2—hepatitis B	4.1e-05	0.000314	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—AKR1B1—hepatitis B	4.09e-05	0.000313	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	4.06e-05	0.00031	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-A—hepatitis B	4.06e-05	0.00031	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	4.05e-05	0.00031	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	4.03e-05	0.000308	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CTNNB1—hepatitis B	3.99e-05	0.000305	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—TGFB1—hepatitis B	3.97e-05	0.000304	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GOT2—hepatitis B	3.94e-05	0.000301	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GGT2—hepatitis B	3.92e-05	0.0003	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—CDKN1A—hepatitis B	3.89e-05	0.000298	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—PTEN—hepatitis B	3.88e-05	0.000297	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—NFKB1—hepatitis B	3.87e-05	0.000296	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CCR5—hepatitis B	3.84e-05	0.000294	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CTNNB1—hepatitis B	3.81e-05	0.000291	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HLA-A—hepatitis B	3.74e-05	0.000286	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CDKN1A—hepatitis B	3.74e-05	0.000286	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—PTEN—hepatitis B	3.73e-05	0.000285	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—CDKN1A—hepatitis B	3.72e-05	0.000285	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PTEN—hepatitis B	3.71e-05	0.000284	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—NFKB1—hepatitis B	3.71e-05	0.000284	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—TLR4—hepatitis B	3.71e-05	0.000284	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HLA-DRB1—hepatitis B	3.71e-05	0.000283	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL2—hepatitis B	3.57e-05	0.000273	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—hepatitis B	3.55e-05	0.000271	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CXCL10—hepatitis B	3.47e-05	0.000265	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CTNNB1—hepatitis B	3.44e-05	0.000263	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	3.41e-05	0.000261	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GGT1—hepatitis B	3.4e-05	0.00026	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GOT1—hepatitis B	3.4e-05	0.00026	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CDKN1A—hepatitis B	3.36e-05	0.000257	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	3.36e-05	0.000257	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PTEN—hepatitis B	3.35e-05	0.000257	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—F2—hepatitis B	3.35e-05	0.000256	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NFKB1—hepatitis B	3.34e-05	0.000255	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—NOS2—hepatitis B	3.31e-05	0.000253	CbGpPWpGaD
Tacrolimus—MTOR—Disease—NOS2—hepatitis B	3.26e-05	0.000249	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—hepatitis B	3.24e-05	0.000248	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP2A6—hepatitis B	3.15e-05	0.000241	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	3.14e-05	0.00024	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—TGFB1—hepatitis B	3.08e-05	0.000236	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—hepatitis B	2.99e-05	0.000229	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GOT2—hepatitis B	2.85e-05	0.000218	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TGFB1—hepatitis B	2.78e-05	0.000213	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL2—hepatitis B	2.76e-05	0.000211	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	2.76e-05	0.000211	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP2A6—hepatitis B	2.71e-05	0.000208	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IFNG—hepatitis B	2.71e-05	0.000207	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CCR5—hepatitis B	2.69e-05	0.000206	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CTNNB1—hepatitis B	2.67e-05	0.000204	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CD4—hepatitis B	2.61e-05	0.0002	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CDKN1A—hepatitis B	2.61e-05	0.000199	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PTEN—hepatitis B	2.6e-05	0.000199	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NFKB1—hepatitis B	2.59e-05	0.000198	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—AKR1B1—hepatitis B	2.52e-05	0.000193	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GGT1—hepatitis B	2.46e-05	0.000188	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GOT1—hepatitis B	2.46e-05	0.000188	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GOT2—hepatitis B	2.45e-05	0.000188	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—hepatitis B	2.43e-05	0.000186	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GGT2—hepatitis B	2.42e-05	0.000185	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CD4—hepatitis B	2.41e-05	0.000185	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL2—hepatitis B	2.4e-05	0.000184	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2A6—hepatitis B	2.38e-05	0.000182	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CTNNB1—hepatitis B	2.32e-05	0.000178	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—hepatitis B	2.32e-05	0.000177	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—F2—hepatitis B	2.31e-05	0.000177	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TP53—hepatitis B	2.29e-05	0.000175	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CDKN1A—hepatitis B	2.27e-05	0.000173	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PTEN—hepatitis B	2.26e-05	0.000173	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IL2—hepatitis B	2.25e-05	0.000172	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—NFKB1—hepatitis B	2.25e-05	0.000172	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TGFB1—hepatitis B	2.16e-05	0.000165	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GOT2—hepatitis B	2.15e-05	0.000164	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CTNNB1—hepatitis B	2.14e-05	0.000164	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GGT1—hepatitis B	2.12e-05	0.000162	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GOT1—hepatitis B	2.12e-05	0.000162	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	2.11e-05	0.000161	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—hepatitis B	2.1e-05	0.00016	CbGpPWpGaD
Tacrolimus—MTOR—Disease—CDKN1A—hepatitis B	2.09e-05	0.00016	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PTEN—hepatitis B	2.09e-05	0.00016	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.93e-05	0.000148	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GGT1—hepatitis B	1.86e-05	0.000142	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GOT1—hepatitis B	1.86e-05	0.000142	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ALB—hepatitis B	1.81e-05	0.000138	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TP53—hepatitis B	1.78e-05	0.000136	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TGFB1—hepatitis B	1.76e-05	0.000134	CbGpPWpGaD
Tacrolimus—MTOR—Disease—TGFB1—hepatitis B	1.73e-05	0.000132	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—hepatitis B	1.62e-05	0.000124	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL2—hepatitis B	1.55e-05	0.000119	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CTNNB1—hepatitis B	1.5e-05	0.000115	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CDKN1A—hepatitis B	1.47e-05	0.000112	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.46e-05	0.000112	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PTEN—hepatitis B	1.46e-05	0.000112	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NFKB1—hepatitis B	1.46e-05	0.000111	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—TP53—hepatitis B	1.45e-05	0.000111	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—hepatitis B	1.41e-05	0.000108	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PTEN—hepatitis B	1.38e-05	0.000106	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GOT2—hepatitis B	1.32e-05	0.000101	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ALB—hepatitis B	1.31e-05	0.0001	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—hepatitis B	1.3e-05	9.98e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TGFB1—hepatitis B	1.21e-05	9.28e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GGT1—hepatitis B	1.14e-05	8.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GOT1—hepatitis B	1.14e-05	8.75e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TP53—hepatitis B	9.98e-06	7.64e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PTEN—hepatitis B	9.98e-06	7.63e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ALB—hepatitis B	9.87e-06	7.55e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—hepatitis B	9.14e-06	6.99e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PTEN—hepatitis B	8.6e-06	6.57e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PTEN—hepatitis B	7.53e-06	5.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ALB—hepatitis B	6.08e-06	4.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PTEN—hepatitis B	4.64e-06	3.55e-05	CbGpPWpGaD
